Verified ProfileEN

Hebei Veyong Pharmaceutical Co., Ltd.

Order verification — $199

Manufacturing · Veterinary Drug Manufacturing

Verification dossier

Hebei Veyong Pharmaceutical Co., Ltd. is a Chinese company based in Shijiazhuang, Hebei. The company operates in the veterinary drug manufacturing sector, within the broader manufacturing industry. Established 2002, the company has been operating for 24 years.

Sinolinks tracks Hebei Veyong Pharmaceutical Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed projects: veterinary drug production; veterinary drug operation; feed additive production; feed production; disinfectant production (excluding hazardous chemicals); pesticide retail. General projects: feed additive sales; disinfectant sales (excluding hazardous chemicals); pet food and supplies wholesale; pet food and supplies retail; sanitary insecticide sales; veterinary specific equipment sales; chemical product sales (excluding licensed chemical products); goods import and export; internet sales (excluding licensed goods); non-metallic minerals and products sales; metal ore sales; technical services, technical development, technical consulting, technical exchange, technology transfer, technology promotion.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review